BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang LS, Chow KC, Wu CW. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate. Br J Cancer 1999;80:1617-22. [PMID: 10408408 DOI: 10.1038/sj.bjc.6690571] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang YF, Chow KC, Chang SY, Chiu JH, Tai SK, Li WY, Wang LS. Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. Br J Cancer 2004;90:2186-93. [PMID: 15150613 DOI: 10.1038/sj.bjc.6601808] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
2 Yang P, Huang P, Yong L, Chang Y, Wu C, Hua K, Hsieh M, Lee J. Circulating Interleukin-6 is Associated with Prognosis and Genetic Polymorphisms of MIR608 in Patients with Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2018;25:2449-56. [DOI: 10.1245/s10434-018-6532-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Safley SA, Villinger F, Jackson EH, Tucker-Burden C, Cohen C, Weber CJ. Interleukin-6 production and secretion by human parathyroids. Clin Exp Immunol 2004;136:145-56. [PMID: 15030526 DOI: 10.1111/j.1365-2249.2004.02419.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
4 Matzaraki V, Alexandraki KI, Venetsanou K, Piperi C, Myrianthefs P, Malamos N, Giannakakis T, Karatzas S, Diamanti-Kandarakis E, Baltopoulos G. Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem 2007;40:336-42. [PMID: 17306245 DOI: 10.1016/j.clinbiochem.2006.10.027] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
5 Yuan A, Liu J, Liu Y, Cui G. Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas. Pathol Oncol Res 2007;13:321-5. [PMID: 18158567 DOI: 10.1007/BF02940311] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Wakatsuki K, Matsumoto S, Migita K, Ito M, Kunishige T, Nakade H, Nakatani M, Kitano M, Sho M. Preoperative Plasma Fibrinogen is Associated with Lymph Node Metastasis and Predicts Prognosis in Resectable Esophageal Cancer. World J Surg 2017;41:2068-77. [DOI: 10.1007/s00268-017-3991-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
7 Goh M, Chen F, Paulsen MT, Yeager AM, Dyer ES, Ljungman M. Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cells. Neoplasia 2001;3:331-8. [PMID: 11571633 DOI: 10.1038/sj.neo.7900165] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
8 Iizuka N, Miyamoto K, Hazama S, Yoshino S, Yoshimura K, Okita K, Fukumoto T, Yamamoto S, Tangoku A, Oka M. Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett 2000;158:35-41. [PMID: 10940506 DOI: 10.1016/s0304-3835(00)00496-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
9 Kuo K, Chou T, Hsu H, Chen W, Wang L. Prognostic Significance of NBS1 and Snail Expression in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2012;19:549-57. [DOI: 10.1245/s10434-011-2043-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
10 Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B. Association of interleukin-6 (−174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: An exploratory study. Clinical Immunology 2008;128:199-204. [DOI: 10.1016/j.clim.2008.03.519] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chen D, Chu C, Chen C, Yang H, Chiang Y, Lin T, Chiang I, Chuang D, Yu C, Chow K. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas. J Pathol 2008;215:290-9. [DOI: 10.1002/path.2361] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
12 Wang Y, Chang S, Tai S, Li W, Wang L. Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck 2002;24:850-8. [DOI: 10.1002/hed.10145] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
13 Okamura A, Yamashita K, Kozuki R, Takahashi K, Toihata T, Imamura Y, Mine S, Watanabe M. Inflammatory response and recurrence after minimally invasive esophagectomy. Langenbecks Arch Surg 2019;404:761-9. [DOI: 10.1007/s00423-019-01818-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Chakravortty D, Koide N, Kato Y, Sugiyama T, Mu MM, Yoshida T, Yokochi T. The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells. Journal of Endotoxin Research 2000;6:243-7. [DOI: 10.1177/09680519000060030501] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 10.2] [Reference Citation Analysis]
15 Soares-Lima SC, Gonzaga IM, Camuzi D, Nicolau-Neto P, Vieira da Silva R, Guaraldi S, Ferreira MA, Hernandez-Vargas H, Herceg Z, Ribeiro Pinto LF. IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:722417. [PMID: 34422669 DOI: 10.3389/fonc.2021.722417] [Reference Citation Analysis]
16 Yuzhalin AE, Kutikhin AG. IL-6 Family and Cancer. Interleukins in Cancer Biology. Elsevier; 2015. pp. 117-46. [DOI: 10.1016/b978-0-12-801121-8.00005-1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Grimm C, Six L, Tomovski C, Speiser P, Joura E, Zeillinger R, Sliutz G, Reinthaller A, Hefler LA. A Common Interleukin-6 Promoter Polymorphism in Patients With Vulvar Cancer. Journal of the Society for Gynecologic Investigation 2016;12:617-20. [DOI: 10.1016/j.jsgi.2005.08.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
18 Groblewska M, Mroczko B, Sosnowska D, Szmitkowski M. Interleukin 6 and C-reactive protein in esophageal cancer. Clinica Chimica Acta 2012;413:1583-90. [DOI: 10.1016/j.cca.2012.05.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
19 Maeda Y, Takeuchi H, Matsuda S, Okamura A, Fukuda K, Miyasho T, Nakamura R, Suda K, Wada N, Kawakubo H, Kitagawa Y. Clinical significance of preoperative serum concentrations of interleukin-6 as a prognostic marker in patients with esophageal cancer. Esophagus 2020;17:279-88. [PMID: 31845119 DOI: 10.1007/s10388-019-00708-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Fang HY, Lin TS, Lin JP, Wu YC, Chow KC, Wang LS. Cyclooxygenase-2 in human non-small cell lung cancer. Eur J Surg Oncol. 2003;29:171-177. [PMID: 12633561 DOI: 10.1053/ejso.2002.1316] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
21 Göransson M, Elias E, Ståhlberg A, Olofsson A, Andersson C, Aman P. Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression. Int J Cancer 2005;115:556-60. [PMID: 15688424 DOI: 10.1002/ijc.20893] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
22 Wang HW, Lin CP, Chiu JH, Chow KC, Kuo KT, Lin CS, Wang LS. Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin. Int J Cancer 2007;120:2019-27. [PMID: 17266043 DOI: 10.1002/ijc.22402] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 4.7] [Reference Citation Analysis]
23 Fujiwara H, Suchi K, Okamura S, Okamura H, Umehara S, Todo M, Shiozaki A, Kubota T, Ichikawa D, Okamoto K, Ochiai T, Kokuba Y, Sonoyama T, Otsuji E. Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer. J Surg Oncol 2011;103:62-8. [DOI: 10.1002/jso.21751] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
24 Wang LS, Chow KC, Wu YC, Lin TY, Li WY. Inverse expression of dihydrodiol dehydrogenase and glutathione-S-transferase in patients with esophageal squamous cell carcinoma. Int J Cancer. 2004;111:246-251. [PMID: 15197778 DOI: 10.1002/ijc.11650] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
25 Kuo KT, Chen CL, Chou TY, Yeh CT, Lee WH, Wang LS. Nm23H1 mediates tumor invasion in esophageal squamous cell carcinoma by regulation of CLDN1 through the AKT signaling. Oncogenesis 2016;5:e239. [PMID: 27376780 DOI: 10.1038/oncsis.2016.46] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
26 Tsutsui M, Kawakubo H, Hayashida T, Fukuda K, Nakamura R, Takahashi T, Wada N, Saikawa Y, Omori T, Takeuchi H, Kitagawa Y. Comprehensive screening of genes resistant to an anticancer drug in esophageal squamous cell carcinoma. Int J Oncol 2015;47:867-74. [PMID: 26202837 DOI: 10.3892/ijo.2015.3085] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
27 Chang MC, Wu HL, Lee JJ, Lee PH, Chang HH, Hahn LJ, Lin BR, Chen YJ, Jeng JH. The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J Biol Chem. 2004;279:50676-50683. [PMID: 15375172 DOI: 10.1074/jbc.m404465200] [Cited by in Crossref: 100] [Cited by in F6Publishing: 28] [Article Influence: 5.9] [Reference Citation Analysis]
28 Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Seminars in Immunology. 2014;26:54-74. [PMID: 24552665 DOI: 10.1016/j.smim.2014.01.001] [Cited by in Crossref: 319] [Cited by in F6Publishing: 320] [Article Influence: 45.6] [Reference Citation Analysis]
29 Kuo KT, Wang HW, Chou TY, Hsu WH, Hsu HS, Lin CH, Wang LS. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma. Ann Surg Oncol. 2009;16:352-360. [PMID: 19050969 DOI: 10.1245/s10434-008-0242-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
30 Kuo KT, Chow KC, Wu YC, Lin CS, Wang HW, Li WY, Wang LS. Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma. Ann Thorac Surg. 2003;76:909-914. [PMID: 12963227 DOI: 10.1016/S0003-4975(03)00717-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
31 Zagury D, Le Buanec H, Bizzini B, Burny A, Lewis G, Gallo RC. Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases. Cytokine Growth Factor Rev. 2003;14:123-137. [PMID: 12651224 DOI: 10.1016/s1359-6101(03)00004-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
32 Ikeda M, Natsugoe S, Ueno S, Baba M, Aikou T. Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg. 2003;238:197-202. [PMID: 12894012 DOI: 10.1097/01.sla.0000080822.22415.cb] [Cited by in Crossref: 53] [Cited by in F6Publishing: 79] [Article Influence: 2.9] [Reference Citation Analysis]
33 Xie JJ, Xu LY, Wu JY, Shen ZY, Zhao Q, Du ZP, Lv Z, Gu W, Pan F, Xu XE. Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. Am J Pathol. 2010;176:939-951. [PMID: 20056838 DOI: 10.2353/ajpath.2010.090118] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
34 Vanden Berghe W, De Bosscher K, Vermeulen L, De Wilde G, Haegeman G. Induction and repression of NF-kappa B-driven inflammatory genes. Ernst Schering Res Found Workshop 2002;:233-78. [PMID: 12355719 DOI: 10.1007/978-3-662-04660-9_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
35 Vanden Berghe W, Vermeulen L, De Wilde G, De Bosscher K, Boone E, Haegeman G. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem Pharmacol 2000;60:1185-95. [PMID: 11007957 DOI: 10.1016/s0006-2952(00)00412-3] [Cited by in Crossref: 206] [Cited by in F6Publishing: 72] [Article Influence: 9.8] [Reference Citation Analysis]